Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,781 | -14,438 | -12,300 | -14,260 | -26,616 |
| Depreciation Amortization | 3 | 3 | 4 | 3 | 2 |
| Accounts receivable | N/A | N/A | N/A | N/A | 84 |
| Other Working Capital | 1,639 | 1,391 | 400 | 1,250 | -4,756 |
| Other Operating Activity | 4,292 | 851 | 763 | -353 | 16,513 |
| Operating Cash Flow | $-10,847 | $-12,193 | $-11,133 | $-13,360 | $-14,773 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -4 | -10 | N/A |
| Net Acquisitions | N/A | N/A | N/A | N/A | 3,279 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -3,333 |
| Investing Cash Flow | $N/A | $N/A | $-4 | $-10 | $-54 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,250 |
| Debt Repayment | -320 | -426 | -391 | -790 | -1,433 |
| Common Stock Issued | 128,238 | 8,446 | 9,436 | 14,401 | 5,209 |
| Common Stock Repurchased | 7,635 | 2,506 | 2,758 | 2,274 | -99 |
| Other Financing Activity | -1,113 | -944 | -617 | -627 | 19,682 |
| Financing Cash Flow | $134,440 | $9,582 | $11,186 | $15,258 | $24,609 |
| Beginning Cash Position | 9,847 | 12,458 | 12,409 | 10,521 | 739 |
| End Cash Position | 133,440 | 9,847 | 12,458 | 12,409 | 10,521 |
| Net Cash Flow | $123,593 | $-2,611 | $49 | $1,888 | $9,782 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,847 | -12,193 | -11,133 | -13,360 | -14,773 |
| Capital Expenditure | N/A | N/A | -4 | -10 | N/A |
| Free Cash Flow | -10,847 | -12,193 | -11,137 | -13,370 | -14,773 |